Purple for a Purpose partner and Inspira founder Rachel shares about her mom's journey with lupus and how it inspired her company.
Hispanic Heritage Month is a time to celebrate the histories, cultures, and contributions of Hispanic and Latino communities. It is also an opportunity to recognize how lupus affects these communities ...
Beginning in September, people living with lupus, along with their families and friends, advocates, supporters and community leaders will come together for the Lupus Foundation of America’s (LFA) 2026 ...
Novartis and Bristol Myers Squibb have paused their clinical trials studying their respective CAR-T cell therapies for lupus and other autoimmune diseases while they review safety findings. Novartis ...
An international group of lupus researchers have developed a new measurement tool to assess brain fog and cognitive symptoms in people with systemic lupus erythematosus (SLE). The Lupus Brain Fog ...
New research is shedding light on the biological mechanisms that may help explain why systemic lupus erthyematosus (SLE) and other autoimmune diseases are more common in women. Two studies from the ...
Yesterday, the House Appropriations Committee approved the Fiscal Year 2027 Defense Appropriations bill, which includes $10 million for the Department of Defense (DoD) Lupus Research Program (LRP). In ...
In a new study, researchers found achieving low disease activity or remission is possible and meaningful for people with lupus nephritis, (LN, lupus-related kidney disease) once their kidneys start ...
June is Men’s Health Month, a time to shine light on the health challenges that affect men with lupus and encourage open, honest conversations about care and well-being. For the lupus community, this ...
In a new study, researchers found low glomerular filtration rate (eGFR, a measure used to assess how well the kidneys filter blood) and chronic histologic damage predicted eGFR loss in people with ...
The U.S. Food & Drug Administration (FDA) has granted approval for subcutaneous administration of anifrolumab (SAPHNELO) for treatment of people living with moderately to severely active ...
Join us for this webinar to learn how lupus can affect the central nervous system (CNS), including neuropsychiatric lupus (NPSLE) and gain a better understanding of common NPSLE symptoms. We’ll also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results